This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
NMBA
NMBD
Standards/Guidelines
2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade
Neuromuscular blockade in children
Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study
Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care
Physiology
Development of the neuromuscular junction and neuromuscular blocking agents in neonates, infants and children: A narrative review
Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.
Pseudocholinesterase Deficiency
Antiepileptic-Induced Resistance to Neuromuscular Blockers: Mechanisms and Clinical Significance
Monitoring
Neuromuscular block management: evidence-based principles and practice
Quantitative Neuromuscular Monitoring and Postoperative Outcomes: A Narrative Review
Neuromuscular Monitoring in the Perioperative Period
Leg lift and maximum inspiratory force, clinical signs of neuromuscular blockade reversal in neonates and infants
Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data
Intraoperative neuromuscular monitoring site and residual paralysis
Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative
Pediatric Intraoperative Electromyographic Responses at the Adductor Pollicis and Flexor Hallucis Brevis Muscles: A Prospective, Comparative Analysis
Accuracy and Precision of Three Acceleromyographs, Three Electromyographs, and a Mechanomyograph Measuring the Train-of-four Ratio in the Absence of Neuromuscular Blocking Drugs
Skin Injury after Removal of Electrode Used for Quantitative Monitoring of Neuromuscular Transmission
Agents
Depolarizing
Succinylcholine
The place of suxamethonium in pediatric anesthesia
Failure of succinylcholine to alter plasma potassium in children with myelomeningocoele
Non-Depolarizing
Rocuronium
Intramuscular rocuronium
Bioavailability of intramuscular rocuronium in infants and children
Goldilocks and the Three Rocuronium Reversals: A Sugammadex Dose-finding Study
Optimal rocuronium dose for intubation during inhalation induction with sevoflurane in children
Intramuscular rocuronium in infants and children: a multicenter study to evaluate tracheal intubating conditions, onset, and duration of action
Test Your Knowledge: unique advantage of rocuronium
Vecuronium
Cis-atracurium
Antagonism/Reversal
Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube
A Survey of the Society for Pediatric Anesthesia on the Use, Monitoring, and Antagonism of Neuromuscular Blockade
Measuring Success of Patient Safety Initiatives: The 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade
A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis
Sugammadex
StatPearls: Sugammadex
Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children
Encapsulation dynamics of neuromuscular blocking drugs by sugammadex
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis
Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study
Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study
Safety of sugammadex for myasthaenia gravis patients undergoing general anaesthesia: a retrospective database study
Advantages and pitfalls of clinical application of sugammadex
Cardiac arrest following sugammadex administration
Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex
A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis
A retrospective observational cross-sectional study of intraoperative neuromuscular blocking agent choice and dosing in a US paediatric referral hospital before and after introduction of sugammadex
Sugammadex Vial Wastage: Implications for the Cost of Anesthesia Care in Children: Research Letter
Recurarisation after sugammadex in children: review of case reports and recommendations
Factors Associated With Decision to Use and Dosing of Sugammadex in Children: A Retrospective Cross-Sectional Observational Study
Impact of Sugammadex Introduction on Using Neuromuscular Blockade and Endotracheal Intubation in a Pediatric Hospital: A Retrospective, Observational Cross-Sectional Study
X tweet about sugammadex
Unintended Consequences: Is Sugammadex Changing the Way We Deliver Anesthesia?
Heart rate changes following the administration of sugammadex in children: a prospective, observational study
Sugammadex for reversal of neuromuscular blockade in neonates and infants <2 years old: results from a phase IV randomized clinical trial
Sugammadex and neuromuscular reversal: Special focus on neonatal and infant populations
Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children
Current evidence for the use of sugammadex in children
Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age
Sugammadex Is Not a Silver Bullet: Caveats Regarding Unmonitored Reversal
A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis
Sugammadexand Women, Hormonal Regulation, and Contraceptives,
A prospective observational study of the effects of sugammadex on peri-operative oestrogen and progesterone levels in women who take hormonal contraception
What we need to know and do on sugammadex usage in pregnant and lactating women and those on hormonal contraceptives
Safety of Sugammadex in Pregnancy, Pediatrics, and Renal Failure
Neostigmine
Rocuronium-Sugammadex Versus Cisatracurium-Neostigmine in Kidney Disease: Making Sense of Surprising Results
Management of Muscle Relaxation With Rocuronium and Reversal With Neostigmine or Sugammadex Guided by Quantitative Neuromuscular Monitoring
Anaphylaxis
Sugammadex and rocuronium-induced anaphylaxis
Sugammadex in the management of rocuronium-induced anaphylaxis
Role of sugammadex in the treatment of anaphylaxis due to rocuronium in children: Extrapolation from adult and animal reports
The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?
Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study
Sugammadex hypersensitivity: a multicentre retrospective analysis of a large Australian cohort
Drug challenge testing: a critical step in the investigation of neuromuscular blocking agent hypersensitivity
Incidence of immediate hypersensitivity to sugammadex in Aotearoa New Zealand: a retrospective cohort study
Historic
Gallamine
Micacurium
Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury
Curare